Tvardi Therapeutics (TVRD) Gross Profit (2022 - 2024)
Tvardi Therapeutics' Gross Profit came in at $1.46 million for Q4 2024, down 39.3% from $2.4 million a year earlier and down 43.1% from the prior quarter.
Analysis
Tvardi Therapeutics (TVRD) Gross Profit (2022 - 2024) Analysis & Trends
For FY2024, Tvardi Therapeutics' Gross Profit was $6.52 million, down 55.9% from FY2023.
- Going back by year, Gross Profit was $14.79 million in FY2023 (-57.2%) and $34.6 million in FY2022.
- The five-year range for quarterly Gross Profit is $991,000 (Q2 2024) to $23 million (Q2 2022).
- Year-over-year, Gross Profit has declined for four consecutive quarters, with an average decline of 23.9% over the last eight quarters.
- The fastest year-over-year change in Gross Profit over five years came in Q4 2023 (growth of 111.8%), and the weakest in Q2 2024 (a decline of 82.0%).
- Business Quant data shows TVRD's Gross Profit at $2.56 million (Q3 2024), $991,000 (Q2 2024) and $1.52 million (Q1 2024) in the three quarters before Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Tvardi Therapeutics | 11.73 Mn | 11.73 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 1.46 Mn |
| Sep 30, 2024 | 2.56 Mn |
| Jun 30, 2024 | 991,000.00 |
| Mar 31, 2024 | 1.52 Mn |
| Dec 31, 2023 | 2.40 Mn |
| Sep 30, 2023 | 3.31 Mn |
| Jun 30, 2023 | 5.52 Mn |
| Mar 31, 2023 | 3.58 Mn |
| Dec 31, 2022 | 1.13 Mn |
| Sep 30, 2022 | 7.76 Mn |
| Jun 30, 2022 | 23.00 Mn |
| Mar 31, 2022 | 2.71 Mn |
API Access
Tvardi Therapeutics Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=TVRD&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "TVRD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=TVRD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();